ID   ERBB4_RAT               Reviewed;        1308 AA.
AC   Q62956; Q6UA28; Q6UA29; Q9Z2N7;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   06-JUN-2002, sequence version 3.
DT   02-OCT-2024, entry version 202.
DE   RecName: Full=Receptor tyrosine-protein kinase erbB-4;
DE            EC=2.7.10.1;
DE   AltName: Full=Proto-oncogene-like protein c-ErbB-4;
DE   Contains:
DE     RecName: Full=ERBB4 intracellular domain;
DE              Short=4ICD;
DE              Short=E4ICD;
DE     AltName: Full=s80HER4;
DE   Flags: Precursor;
GN   Name=Erbb4; Synonyms=Tyro-2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM JM-A CYT1).
RC   TISSUE=Heart;
RX   PubMed=9553078; DOI=10.1074/jbc.273.17.10261;
RA   Zhao Y.-Y., Sawyer D.R., Baliga R.R., Opel D.J., Han X., Marchionni M.A.,
RA   Kelly R.A.;
RT   "Neuregulins promote survival and growth of cardiac myocytes. Persistence
RT   of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes.";
RL   J. Biol. Chem. 273:10261-10269(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS JM-A CYT1 AND JM-A CYT2).
RC   STRAIN=Wistar; TISSUE=Olfactory bulb;
RX   PubMed=15355992; DOI=10.1074/jbc.m408374200;
RA   Gambarotta G., Garzotto D., Destro E., Mautino B., Giampietro C.,
RA   Cutrupi S., Dati C., Cattaneo E., Fasolo A., Perroteau I.;
RT   "ErbB4 expression in neural progenitor cells (ST14A) is necessary to
RT   mediate neuregulin-1-beta1-induced migration.";
RL   J. Biol. Chem. 279:48808-48816(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 848-901.
RC   TISSUE=Sciatic nerve;
RX   PubMed=2025425; DOI=10.1016/0896-6273(91)90167-x;
RA   Lai C., Lemke G.;
RT   "An extended family of protein-tyrosine kinase genes differentially
RT   expressed in the vertebrate nervous system.";
RL   Neuron 6:691-704(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1031-1198.
RC   STRAIN=Sprague-Dawley; TISSUE=Spinal cord;
RX   PubMed=9030624; DOI=10.1523/jneurosci.17-05-01642.1997;
RA   Carroll S.L., Miller M.L., Frohnert P.W., Kim S.S., Corbett J.A.;
RT   "Expression of neuregulins and their putative receptors, ErbB2 and ErbB3,
RT   is induced during Wallerian degeneration.";
RL   J. Neurosci. 17:1642-1659(1997).
RN   [5]
RP   FUNCTION.
RX   PubMed=10839362; DOI=10.1016/s0896-6273(00)81176-9;
RA   Huang Y.Z., Won S., Ali D.W., Wang Q., Tanowitz M., Du Q.S., Pelkey K.A.,
RA   Yang D.J., Xiong W.C., Salter M.W., Mei L.;
RT   "Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS
RT   synapses.";
RL   Neuron 26:443-455(2000).
RN   [6]
RP   FUNCTION, AND ACTIVITY REGULATION.
RX   PubMed=14654373; DOI=10.1016/j.yjmcc.2003.09.012;
RA   Fukazawa R., Miller T.A., Kuramochi Y., Frantz S., Kim Y.D.,
RA   Marchionni M.A., Kelly R.A., Sawyer D.B.;
RT   "Neuregulin-1 protects ventricular myocytes from anthracycline-induced
RT   apoptosis via erbB4-dependent activation of PI3-kinase/Akt.";
RL   J. Mol. Cell. Cardiol. 35:1473-1479(2003).
RN   [7]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=12716924; DOI=10.1523/jneurosci.23-08-03164.2003;
RA   Ma L., Huang Y.Z., Pitcher G.M., Valtschanoff J.G., Ma Y.H., Feng L.Y.,
RA   Lu B., Xiong W.C., Salter M.W., Weinberg R.J., Mei L.;
RT   "Ligand-dependent recruitment of the ErbB4 signaling complex into neuronal
RT   lipid rafts.";
RL   J. Neurosci. 23:3164-3175(2003).
RN   [8]
RP   FUNCTION AS NRG1 RECEPTOR IN ACTIVATION OF AKT1 AND THE MAP KINASES
RP   MAPK1/ERK2 AND/OR MAPK3/ERK1, AND SUBCELLULAR LOCATION.
RX   PubMed=17250808; DOI=10.1016/j.bbrc.2007.01.009;
RA   Liu Y., Tao Y.M., Woo R.S., Xiong W.C., Mei L.;
RT   "Stimulated ErbB4 internalization is necessary for neuregulin signaling in
RT   neurons.";
RL   Biochem. Biophys. Res. Commun. 354:505-510(2007).
RN   [9]
RP   FUNCTION.
RX   PubMed=17521571; DOI=10.1016/j.neuron.2007.03.028;
RA   Li B., Woo R.S., Mei L., Malinow R.;
RT   "The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation
RT   and plasticity.";
RL   Neuron 54:583-597(2007).
CC   -!- FUNCTION: Tyrosine-protein kinase that plays an essential role as cell
CC       surface receptor for neuregulins and EGF family members and regulates
CC       development of the heart, the central nervous system and the mammary
CC       gland, gene transcription, cell proliferation, differentiation,
CC       migration and apoptosis. Required for normal cardiac muscle
CC       differentiation during embryonic development, and for postnatal
CC       cardiomyocyte proliferation. Required for normal development of the
CC       embryonic central nervous system, especially for normal neural crest
CC       cell migration and normal axon guidance. Required for mammary gland
CC       differentiation, induction of milk proteins and lactation. Acts as
CC       cell-surface receptor for the neuregulins NRG1, NRG2, NRG3 and NRG4 and
CC       the EGF family members BTC, EREG and HBEGF. Ligand binding triggers
CC       receptor dimerization and autophosphorylation at specific tyrosine
CC       residues that then serve as binding sites for scaffold proteins and
CC       effectors. Ligand specificity and signaling is modulated by alternative
CC       splicing, proteolytic processing, and by the formation of heterodimers
CC       with other ERBB family members, thereby creating multiple combinations
CC       of intracellular phosphotyrosines that trigger ligand- and context-
CC       specific cellular responses. Mediates phosphorylation of SHC1 and
CC       activation of the MAP kinases MAPK1/ERK2 and MAPK3/ERK1. Isoform JM-A
CC       CYT-1 and isoform JM-B CYT-1 phosphorylate PIK3R1, leading to the
CC       activation of phosphatidylinositol 3-kinase and AKT1 and protect cells
CC       against apoptosis. Isoform JM-A CYT-1 and isoform JM-B CYT-1 mediate
CC       reorganization of the actin cytoskeleton and promote cell migration in
CC       response to NRG1. Isoform JM-A CYT-2 and isoform JM-B CYT-2 lack the
CC       phosphotyrosine that mediates interaction with PIK3R1, and hence do not
CC       phosphorylate PIK3R1, do not protect cells against apoptosis, and do
CC       not promote reorganization of the actin cytoskeleton and cell
CC       migration. Proteolytic processing of isoform JM-A CYT-1 and isoform JM-
CC       A CYT-2 gives rise to the corresponding soluble intracellular domains
CC       (4ICD) that translocate to the nucleus, promote nuclear import of
CC       STAT5A, activation of STAT5A, mammary epithelium differentiation, cell
CC       proliferation and activation of gene expression. The ERBB4 soluble
CC       intracellular domains (4ICD) colocalize with STAT5A at the CSN2
CC       promoter to regulate transcription of milk proteins during lactation.
CC       The ERBB4 soluble intracellular domains can also translocate to
CC       mitochondria and promote apoptosis. {ECO:0000269|PubMed:10839362,
CC       ECO:0000269|PubMed:12716924, ECO:0000269|PubMed:14654373,
CC       ECO:0000269|PubMed:17250808, ECO:0000269|PubMed:17521571}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};
CC   -!- ACTIVITY REGULATION: Binding of a cognate ligand leads to dimerization
CC       and activation by autophosphorylation on tyrosine residues. In vitro
CC       kinase activity is increased by Mg(2+) (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Monomer in the absence of bound ligand. Homodimer or
CC       heterodimer with another ERBB family member upon ligand binding, thus
CC       forming heterotetramers. Interacts with EGFR and ERBB2. Interacts with
CC       DLG2 (via its PDZ domain), DLG3 (via its PDZ domain), DLG4 (via its PDZ
CC       domain) and SNTB2 (via its PDZ domain). Interacts with MUC1. Interacts
CC       (via its PPxy motifs) with WWOX. Interacts (via the PPxY motif 3 of
CC       isoform JM-A CYT-2) with YAP1 (via the WW domain 1 of isoform 1).
CC       Interacts (isoform JM-A CYT-1 and isoform JM-B CYT-1) with WWP1.
CC       Interacts (via its intracellular domain) with TRIM28. Interacts (via
CC       the intracellular domains of both CYT-1 and CYT-2 isoforms) with KAP1;
CC       the interaction does not phosphorylate KAP1 but represses ERBB4-
CC       mediated transcriptional activity. Interacts with PRPU, DDX23, MATR3,
CC       RBM15, ILF3, KAP1, U5S1, U2SURP, ITCH, HNRNPU, AP2A1, NULC, LEO1, WWP2,
CC       IGHG1, HXK1, GRB7 and SRRT. Interacts (phosphorylated isoform JM-A CYT-
CC       1 and isoform JM-B CYT-1) with PIK3R1. Interacts with SHC1. Interacts
CC       with GRB2. Interacts (soluble intracellular domain) with BCL2.
CC       Interacts (phosphorylated) with STAT1 (By similarity). Interacts with
CC       CBFA2T3. Interacts (soluble intracellular domain) with STAT5A (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:12716924,
CC       ECO:0000269|PubMed:17250808}; Single-pass type I membrane protein
CC       {ECO:0000269|PubMed:12716924, ECO:0000269|PubMed:17250808}. Note=In
CC       response to NRG1 treatment, the activated receptor is internalized.
CC   -!- SUBCELLULAR LOCATION: [ERBB4 intracellular domain]: Nucleus
CC       {ECO:0000250}. Mitochondrion {ECO:0000250}. Note=Following
CC       proteolytical processing E4ICD (E4ICD1 or E4ICD2 generated from the
CC       respective isoforms) is translocated to the nucleus. Significantly more
CC       E4ICD2 than E4ICD1 is found in the nucleus. E4ICD2 derived from
CC       processing of isoform JM-A CYT-2 colocalizes with YAP1 in the nucleus
CC       (By similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=JM-A CYT1; Synonyms=JMa cyt1;
CC         IsoId=Q62956-1; Sequence=Displayed;
CC       Name=JM-A CYT2; Synonyms=JMa cyt2;
CC         IsoId=Q62956-2; Sequence=VSP_022150;
CC   -!- TISSUE SPECIFICITY: Preferentially expressed in the developing nervous
CC       system. Exhibits distinct and highly regionalized patterns of
CC       expression in the adult brain, where it is mainly found in the
CC       reticular nucleus of the thalamus. Very low levels in kidney, and
CC       heart.
CC   -!- PTM: Isoform JM-A CYT-2 and isoform JM-A CYT-1 are processed by ADAM17.
CC       Proteolytic processing in response to ligand or 12-O-
CC       tetradecanoylphorbol-13-acetate stimulation results in the production
CC       of 120 kDa soluble receptor forms and intermediate membrane-anchored 80
CC       kDa fragments, which are further processed by a presenilin-dependent
CC       gamma-secretase to release the respective cytoplasmic intracellular
CC       domain E4ICD (either E4ICD1/s80Cyt1 or E4ICD2/s80Cyt2) (By similarity).
CC       {ECO:0000250}.
CC   -!- PTM: Autophosphorylated on tyrosine residues in response to ligand
CC       binding. Autophosphorylation occurs in trans, i.e. one subunit of the
CC       dimeric receptor phosphorylates tyrosine residues on the other subunit.
CC       Ligands trigger phosphorylation at specific tyrosine residues, thereby
CC       creating binding sites for scaffold proteins and effectors.
CC       Constitutively phosphorylated at a basal level when overexpressed in
CC       heterologous systems; ligand binding leads to increased
CC       phosphorylation. Phosphorylation at Tyr-1035 is important for
CC       interaction with STAT1. Phosphorylation at Tyr-1056 is important for
CC       interaction with PIK3R1. Phosphorylation at Tyr-1242 is important for
CC       interaction with SHC1. Phosphorylation at Tyr-1188 may also contribute
CC       to the interaction with SHC1. Isoform JM-A CYT-2 is constitutively
CC       phosphorylated on tyrosine residues in a ligand-independent manner.
CC       E4ICD2 but not E4ICD1 is phosphorylated on tyrosine residues (By
CC       similarity). {ECO:0000250}.
CC   -!- PTM: Ubiquitinated. During mitosis, the ERBB4 intracellular domain is
CC       ubiquitinated by the APC/C complex and targeted to proteasomal
CC       degradation. Isoform JM-A CYT-1 and isoform JM-B CYT-1 are
CC       ubiquitinated by WWP1. The ERBB4 intracellular domain (E4ICD1) is
CC       ubiquitinated, and this involves NEDD4 (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. EGF receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF041838; AAD08899.1; -; mRNA.
DR   EMBL; AY375306; AAQ77348.1; -; mRNA.
DR   EMBL; AY375307; AAQ77349.1; -; mRNA.
DR   EMBL; U52531; AAC53051.1; -; mRNA.
DR   PIR; PT0184; PT0184.
DR   RefSeq; NP_067719.1; NM_021687.1.
DR   AlphaFoldDB; Q62956; -.
DR   SMR; Q62956; -.
DR   BioGRID; 248766; 4.
DR   STRING; 10116.ENSRNOP00000019283; -.
DR   GlyCosmos; Q62956; 10 sites, No reported glycans.
DR   GlyGen; Q62956; 10 sites.
DR   iPTMnet; Q62956; -.
DR   PhosphoSitePlus; Q62956; -.
DR   SwissPalm; Q62956; -.
DR   PaxDb; 10116-ENSRNOP00000019283; -.
DR   GeneID; 59323; -.
DR   KEGG; rno:59323; -.
DR   UCSC; RGD:620486; rat. [Q62956-1]
DR   AGR; RGD:620486; -.
DR   CTD; 2066; -.
DR   RGD; 620486; Erbb4.
DR   eggNOG; KOG1025; Eukaryota.
DR   InParanoid; Q62956; -.
DR   OrthoDB; 1614410at2759; -.
DR   PhylomeDB; Q62956; -.
DR   BRENDA; 2.7.10.1; 5301.
DR   Reactome; R-RNO-1227986; Signaling by ERBB2.
DR   Reactome; R-RNO-1236394; Signaling by ERBB4.
DR   Reactome; R-RNO-1250196; SHC1 events in ERBB2 signaling.
DR   Reactome; R-RNO-1250342; PI3K events in ERBB4 signaling.
DR   Reactome; R-RNO-1250347; SHC1 events in ERBB4 signaling.
DR   Reactome; R-RNO-1251985; Nuclear signaling by ERBB4.
DR   Reactome; R-RNO-1253288; Downregulation of ERBB4 signaling.
DR   Reactome; R-RNO-1257604; PIP3 activates AKT signaling.
DR   Reactome; R-RNO-1963640; GRB2 events in ERBB2 signaling.
DR   Reactome; R-RNO-1963642; PI3K events in ERBB2 signaling.
DR   Reactome; R-RNO-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-RNO-6785631; ERBB2 Regulates Cell Motility.
DR   Reactome; R-RNO-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling.
DR   Reactome; R-RNO-8847993; ERBB2 Activates PTK6 Signaling.
DR   Reactome; R-RNO-8863795; Downregulation of ERBB2 signaling.
DR   Reactome; R-RNO-9018519; Estrogen-dependent gene expression.
DR   PRO; PR:Q62956; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0009925; C:basal plasma membrane; IBA:GO_Central.
DR   GO; GO:0016323; C:basolateral plasma membrane; ISO:RGD.
DR   GO; GO:0005901; C:caveola; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0098982; C:GABA-ergic synapse; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0060077; C:inhibitory synapse; IDA:RGD.
DR   GO; GO:0005739; C:mitochondrion; ISO:RGD.
DR   GO; GO:0031594; C:neuromuscular junction; ISO:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0098839; C:postsynaptic density membrane; ISO:RGD.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:UniProtKB.
DR   GO; GO:0042734; C:presynaptic membrane; ISO:RGD.
DR   GO; GO:0043235; C:receptor complex; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005006; F:epidermal growth factor receptor activity; ISO:RGD.
DR   GO; GO:0005154; F:epidermal growth factor receptor binding; ISO:RGD.
DR   GO; GO:0050811; F:GABA receptor binding; ISO:RGD.
DR   GO; GO:0038131; F:neuregulin receptor activity; IDA:MGI.
DR   GO; GO:0042803; F:protein homodimerization activity; ISO:RGD.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0004714; F:transmembrane receptor protein tyrosine kinase activity; ISS:UniProtKB.
DR   GO; GO:0061026; P:cardiac muscle tissue regeneration; ISS:UniProtKB.
DR   GO; GO:0045165; P:cell fate commitment; ISO:RGD.
DR   GO; GO:0016477; P:cell migration; ISS:UniProtKB.
DR   GO; GO:0007169; P:cell surface receptor protein tyrosine kinase signaling pathway; ISS:UniProtKB.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; ISO:RGD.
DR   GO; GO:0007259; P:cell surface receptor signaling pathway via JAK-STAT; ISO:RGD.
DR   GO; GO:1905145; P:cellular response to acetylcholine; IEP:RGD.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; ISO:RGD.
DR   GO; GO:1905232; P:cellular response to L-glutamate; IEP:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0021551; P:central nervous system morphogenesis; ISS:UniProtKB.
DR   GO; GO:0009880; P:embryonic pattern specification; ISS:UniProtKB.
DR   GO; GO:0038135; P:ERBB2-ERBB4 signaling pathway; ISO:RGD.
DR   GO; GO:0038130; P:ERBB4 signaling pathway; IDA:MGI.
DR   GO; GO:0038138; P:ERBB4-ERBB4 signaling pathway; ISO:RGD.
DR   GO; GO:0072046; P:establishment of planar polarity involved in nephron morphogenesis; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISS:UniProtKB.
DR   GO; GO:0007595; P:lactation; ISS:UniProtKB.
DR   GO; GO:0060749; P:mammary gland alveolus development; ISS:UniProtKB.
DR   GO; GO:0030879; P:mammary gland development; IEP:RGD.
DR   GO; GO:0060644; P:mammary gland epithelial cell differentiation; ISS:UniProtKB.
DR   GO; GO:0043653; P:mitochondrial fragmentation involved in apoptotic process; ISS:UniProtKB.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0010656; P:negative regulation of muscle cell apoptotic process; IMP:RGD.
DR   GO; GO:0007399; P:nervous system development; ISS:UniProtKB.
DR   GO; GO:0001755; P:neural crest cell migration; ISS:UniProtKB.
DR   GO; GO:0022008; P:neurogenesis; IBA:GO_Central.
DR   GO; GO:0099645; P:neurotransmitter receptor localization to postsynaptic specialization membrane; ISO:RGD.
DR   GO; GO:0021889; P:olfactory bulb interneuron differentiation; ISS:UniProtKB.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; ISS:UniProtKB.
DR   GO; GO:0060045; P:positive regulation of cardiac muscle cell proliferation; ISS:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0050679; P:positive regulation of epithelial cell proliferation; IMP:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; ISS:UniProtKB.
DR   GO; GO:0046326; P:positive regulation of glucose import; IMP:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0071073; P:positive regulation of phospholipid biosynthetic process; IMP:RGD.
DR   GO; GO:2000010; P:positive regulation of protein localization to cell surface; ISO:RGD.
DR   GO; GO:0046427; P:positive regulation of receptor signaling pathway via JAK-STAT; ISS:UniProtKB.
DR   GO; GO:0032230; P:positive regulation of synaptic transmission, GABAergic; IMP:RGD.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; ISS:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:UniProtKB.
DR   GO; GO:0030334; P:regulation of cell migration; ISS:UniProtKB.
DR   GO; GO:0042542; P:response to hydrogen peroxide; IEP:RGD.
DR   GO; GO:0014850; P:response to muscle activity; IEP:RGD.
DR   GO; GO:0031667; P:response to nutrient levels; IEP:RGD.
DR   GO; GO:0032570; P:response to progesterone; IEP:RGD.
DR   GO; GO:0033280; P:response to vitamin D; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0043129; P:surfactant homeostasis; IMP:RGD.
DR   GO; GO:0007416; P:synapse assembly; ISO:RGD.
DR   GO; GO:0060074; P:synapse maturation; IMP:RGD.
DR   GO; GO:0021537; P:telencephalon development; IEP:RGD.
DR   CDD; cd00064; FU; 3.
DR   CDD; cd05110; PTKc_HER4; 1.
DR   CDD; cd12092; TM_ErbB4; 1.
DR   Gene3D; 6.10.250.880; -; 1.
DR   Gene3D; 3.80.20.20; Receptor L-domain; 2.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR006211; Furin-like_Cys-rich_dom.
DR   InterPro; IPR006212; Furin_repeat.
DR   InterPro; IPR032778; GF_recep_IV.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR000494; Rcpt_L-dom.
DR   InterPro; IPR036941; Rcpt_L-dom_sf.
DR   InterPro; IPR050122; RTK.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR049328; TM_ErbB1.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016245; Tyr_kinase_EGF/ERB/XmrK_rcpt.
DR   PANTHER; PTHR24416:SF90; RECEPTOR TYROSINE-PROTEIN KINASE ERBB-4; 1.
DR   PANTHER; PTHR24416; TYROSINE-PROTEIN KINASE RECEPTOR; 1.
DR   Pfam; PF00757; Furin-like; 1.
DR   Pfam; PF14843; GF_recep_IV; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   Pfam; PF01030; Recep_L_domain; 2.
DR   Pfam; PF21314; TM_ErbB1; 1.
DR   PIRSF; PIRSF000619; TyrPK_EGF-R; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00261; FU; 5.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF57184; Growth factor receptor domain; 2.
DR   SUPFAM; SSF52058; L domain-like; 2.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Apoptosis; ATP-binding; Cell membrane;
KW   Developmental protein; Disulfide bond; Glycoprotein; Kinase; Lactation;
KW   Membrane; Mitochondrion; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Receptor; Reference proteome; Repeat; Signal; Transcription;
KW   Transcription regulation; Transferase; Transmembrane; Transmembrane helix;
KW   Tyrosine-protein kinase; Ubl conjugation.
FT   SIGNAL          1..25
FT                   /evidence="ECO:0000255"
FT   CHAIN           26..1308
FT                   /note="Receptor tyrosine-protein kinase erbB-4"
FT                   /id="PRO_0000016675"
FT   CHAIN           676..1308
FT                   /note="ERBB4 intracellular domain"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000396799"
FT   TOPO_DOM        26..651
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        652..675
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        676..1308
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          718..985
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOTIF           676..684
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250"
FT   MOTIF           1032..1035
FT                   /note="PPxy motif 1"
FT   MOTIF           1298..1301
FT                   /note="PPxY motif 2"
FT   MOTIF           1306..1308
FT                   /note="PDZ-binding"
FT   ACT_SITE        843
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10028"
FT   BINDING         724..732
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         751
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         797..799
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         843..848
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         875
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q15303"
FT   MOD_RES         1035
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q15303"
FT   MOD_RES         1056
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q15303"
FT   MOD_RES         1150
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q15303"
FT   MOD_RES         1162
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q15303"
FT   MOD_RES         1188
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q15303"
FT   MOD_RES         1202
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q15303"
FT   MOD_RES         1242
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q15303"
FT   MOD_RES         1258
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q15303"
FT   MOD_RES         1284
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q15303"
FT   CARBOHYD        138
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        174
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        253
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        358
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        410
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        473
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        495
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        548
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        576
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        620
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        29..56
FT                   /evidence="ECO:0000250"
FT   DISULFID        156..186
FT                   /evidence="ECO:0000250"
FT   DISULFID        189..197
FT                   /evidence="ECO:0000250"
FT   DISULFID        193..205
FT                   /evidence="ECO:0000250"
FT   DISULFID        213..221
FT                   /evidence="ECO:0000250"
FT   DISULFID        217..229
FT                   /evidence="ECO:0000250"
FT   DISULFID        230..238
FT                   /evidence="ECO:0000250"
FT   DISULFID        234..246
FT                   /evidence="ECO:0000250"
FT   DISULFID        249..258
FT                   /evidence="ECO:0000250"
FT   DISULFID        262..289
FT                   /evidence="ECO:0000250"
FT   DISULFID        293..304
FT                   /evidence="ECO:0000250"
FT   DISULFID        308..323
FT                   /evidence="ECO:0000250"
FT   DISULFID        326..330
FT                   /evidence="ECO:0000250"
FT   DISULFID        503..512
FT                   /evidence="ECO:0000250"
FT   DISULFID        507..520
FT                   /evidence="ECO:0000250"
FT   DISULFID        523..532
FT                   /evidence="ECO:0000250"
FT   DISULFID        536..552
FT                   /evidence="ECO:0000250"
FT   DISULFID        555..569
FT                   /evidence="ECO:0000250"
FT   DISULFID        559..577
FT                   /evidence="ECO:0000250"
FT   DISULFID        580..589
FT                   /evidence="ECO:0000250"
FT   DISULFID        593..614
FT                   /evidence="ECO:0000250"
FT   DISULFID        617..625
FT                   /evidence="ECO:0000250"
FT   DISULFID        621..633
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1046..1062
FT                   /note="SEIGHSPPPAYTPMSGS -> N (in isoform JM-A CYT2)"
FT                   /evidence="ECO:0000303|PubMed:15355992"
FT                   /id="VSP_022150"
FT   CONFLICT        406
FT                   /note="T -> S (in Ref. 2; AAQ77348/AAQ77349)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        596
FT                   /note="V -> G (in Ref. 2; AAQ77348/AAQ77349)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        951
FT                   /note="I -> M (in Ref. 2; AAQ77348/AAQ77349)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1062
FT                   /note="S -> N (in Ref. 2; AAQ77348 and 4; AAC53051)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1080..1082
FT                   /note="PYT -> SYR (in Ref. 4; AAC53051)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1082
FT                   /note="T -> R (in Ref. 2; AAQ77348/AAQ77349)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1308 AA;  146958 MW;  D944BB0996A08B41 CRC64;
     MKLATGLWVW GSLLVAARTV QPSASQSVCA GTENKLSSLS DLEQQYRALR KYYENCEVVM
     GNLEITSIEH NRDLSFLRSI REVTGYVLVA LNQFRYLPLE NLRIIRGTKL YEDRYALAIF
     LNYRKDGNFG LQELGLKNLT EILNGGVYVD QNKFLCYADT IHWQDIVRNP WPSNMTLVST
     IGSSGCGRCH KSCTGRCWGP TENHCQTLTR TVCAEQCDGR CYGPYVSDCC HRECAGGCSG
     PKDTDCFACM NFNDSGACVT QCPQTFVYNP TTFQLEHNFN AKYTYGAFCV KKCPHNFVVD
     SSSCVRACPS SKMEVEENGI KMCKPCTDIC PKACDGIGTG SLMSAQTVDS SNIDKFINCT
     KINGNLIFLV TGIHGDPYNA IDAIDPEKLN VFRTVREITG FLNIQTWPPN MTDFSVFSNL
     VTIGGRVLYS GLSLLILKQQ GITSLQFQSL KEISAGNIYI TDNSNLCYYH TINWTTLFST
     VNQRIVIRDN RRAENCTAEG MVCNHLCSND GCWGPGPDQC LSCRRFSRGK ICIESCNLYD
     GEFREFENGS ICVECDSQCE KMEDGLLTCH GPGPDNCTKC SHFKDGPNCV EKCPDVLQGA
     NSFIFKYADQ DRECHPCHPN CTQGCNGPTS HDCIYYPWTG HSTLPQHART PLIAAGVIGG
     LFILVIMALT FAVYVRRKSI KKKRALRRFL ETELVEPLTP SGTAPNQAQL RILKETELKR
     VKVLGSGAFG TVYKGIWVPE GETVKIPVAI KILNETTGPK ANVEFMDEAL IMASVDHPHL
     VRLLGVCLSP TIQLVTQLMP HGCLLEYVHE HKDNIGSQLL LNWCVQIAKG MMYLEERRLV
     HRDLAARNVL VKSPNHVKIT DFGLARLLEG DEKEYNADGG KMPIKWMALE CIHYRKFTHQ
     SDVWSYGVTI WELMTFGGKP YDGIPTREIP DLLEKGERLP QPPICTIDVY IVMVKCWMID
     ADSRPKFKEL AAEFSRMARD PQRYLVIQGD DRMKLPSPND SKFFQNLLDE EDLEDMMDAE
     EYLVPQAFNI PPPIYTSRTR IDSNRSEIGH SPPPAYTPMS GSQFVYQDGG FATQQGMPMP
     YTATTSTIPE APVAQGATAE MFDDSCCNGT LRKPVVPHVQ EDSSTQRYSA DPTVFAPERN
     PRAELDEEGY MTPMHDKPKQ EYLNPVEENP FVSRRKNGDL QALDNPEYHS ASSGPPKAED
     EYVNEPLYLN TFTNALGNAE YMKNSLLSVP EKAKKAFDNP DYWNHSLPPR STLQHPDYLQ
     EYSTKYFYKQ NGRIRPIVAE NPEYLSEFSL KPGTMLPPPP YRHRNTVV
//
